Craig A Johnson's Net Worth
$14.4 Million
Who is Craig A Johnson?
Craig A Johnson has an estimated net worth of $14.4 Million. This is based on reported shares across multiple companies, which include Odonate Therapeutics, Inc., Mirati Therapeutics, Inc., HERON THERAPEUTICS, INC. /DE/, PURE BIOSCIENCE, INC., LA JOLLA PHARMACEUTICAL CO, Adamis Pharmaceuticals Corp, NOVADEL PHARMA INC, TorreyPines Therapeutics, Inc., and Ardea Biosciences, Inc./DE.
SEC CIK
Craig A Johnson's CIK is 0001370348
Past Insider Trading and Trends
2020 was Craig A Johnson's most active year for acquiring shares with 9 total transactions. Craig A Johnson's most active month to acquire stocks was the month of December. 2022 was Craig A Johnson's most active year for disposing of shares, totalling 12 transactions. Craig A Johnson's most active month to dispose stocks was the month of July. 2020 saw Craig A Johnson paying a total of $438,600.00 for 120,000 shares, this is the most they've acquired in one year. In 2020 Craig A Johnson cashed out on 30,000 shares for a total of $1,395,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Odonate Therapeutics, Inc. (ODTC) Snapshot price: $3150
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3K |
$17.00 | $51,000.00 | 3K |
Dec 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Mirati Therapeutics, Inc. (MRTX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -17.27K |
—
|
—
|
0
|
Jan 23
| |||
Form 4
| +65.05% | 6.81K |
$58.75 | $399,970.00 | 17.27K |
Dec 29
| |||
Form 4
| +73.81% | 4.44K |
—
|
—
| 10.46K |
Jan 20
| |||
Form 4
| +73.27% | 2.55K |
—
|
—
| 6.02K |
Jan 14
| |||
Form 4
|
—
|
0
|
$116.05 | -$2,865,103.49 | 3.48K |
Scheduled
|
Jan 21
| ||
Form 4
| +73.75% | 1.48K |
—
|
—
| 3.48K |
Jan 15
| |||
Form 4
|
—
|
0
|
$59.42 | -$1,007,400.00 | 2K |
Scheduled
|
Apr 20
| ||
Form 4
|
∞
| 2K |
—
|
—
| 2K |
Jan 3
| |||
Form 4
|
—
|
0
|
$35.06 | -$897,742.51 |
0
|
Scheduled
|
Jan 29
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HERON THERAPEUTICS, INC. /DE/ (HRTX) Snapshot price: $2.32
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +26.89% | 13.95K |
—
|
—
| 65.82K |
Jan 19
| |||
Form 4
| +290.25% | 38.58K |
—
|
—
| 51.87K |
Dec 16
| |||
Form 4
| +330.16% | 10.2K |
$9.73 | -$2,431.93 | 13.29K |
Scheduled
|
Dec 21 - Dec 22
| ||
Form 4
| -7.49% | -250.00 |
$12.30 | -$3,074.10 | 3.09K |
Scheduled
|
Sep 21
| ||
Form 4
| -6.96% | -250.00 |
$15.20 | -$3,800.60 | 3.34K |
Scheduled
|
Jun 21
| ||
Form 4
| -6.51% | -250.00 |
$17.22 | -$4,305.20 | 3.59K |
Scheduled
|
Apr 6
| ||
Form 4
| +357.14% | 3K |
—
|
—
| 3.84K |
Dec 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 12
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PURE BIOSCIENCE, INC. (PURE) Snapshot price: $0.151
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
LA JOLLA PHARMACEUTICAL CO No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -12.00K |
$6.23 | -$74,760.00 |
0
|
Aug 22
| |||
Form 4
|
∞
| 12K |
$3.93 | $47,160.00 | 12K |
Jul 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||